{
  "CitationSubset": [
    "OM"
  ],
  "KeywordList": [
    [
      "ANTI-INFLAMMATORY AGENTS",
      "ANTITUSSIVE AGENTS",
      "ASTHMA",
      "BRONCHIAL NEOPLASMS",
      "BRONCHIECTASIS",
      "COMMON COLD",
      "DRUG THERAPY",
      "OXADIAZOLES",
      "PHARMACOLOGY",
      "PNEUMONIA",
      "RESPIRATORY HYPERSENSITIVITY",
      "RESPIRATORY INSUFFICIENCY",
      "TOXICOLOGIC REPORT",
      "TUBERCULIN TEST"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "14204298",
  "DateCompleted": {
    "Year": "1996",
    "Month": "12",
    "Day": "01"
  },
  "DateRevised": {
    "Year": "2018",
    "Month": "12",
    "Day": "01"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "fre"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0372-042X",
      "JournalIssue": {
        "Volume": "65",
        "PubDate": {
          "Year": "1964",
          "Season": "Aug-Sep"
        }
      },
      "Title": "Toulouse medical",
      "ISOAbbreviation": "Toulouse Med"
    },
    "ArticleTitle": "[AN ANTIPHLOGISTIC AGENT ELECTIVE FOR THE RESPIRATORY TRACT: OXOLAMINE CITRATE. CLINICAL EXPERIMENTATION IN PNEUMOLOGY].",
    "Pagination": {
      "StartPage": "890",
      "EndPage": "901",
      "MedlinePgn": "890-901"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "LAYSSOL",
        "ForeName": "M",
        "Initials": "M"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ],
    "VernacularTitle": "UN ANTIPHLOGISTIQUE ELECTIF DES VOIES RESPIRATOIRES: LE CITRATE D'OXOLAMINE. EXP'ERIMENTATION CLINIQUE EN PNEUMOLOGIE."
  },
  "MedlineJournalInfo": {
    "Country": "France",
    "MedlineTA": "Toulouse Med",
    "NlmUniqueID": "0035523",
    "ISSNLinking": "0372-042X"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Inflammatory Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antitussive Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Oxadiazoles"
    },
    {
      "RegistryNumber": "90BEA145GY",
      "NameOfSubstance": "oxolamine"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Anti-Inflammatory Agents"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Antitussive Agents"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Asthma"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Bronchial Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Bronchiectasis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Common Cold"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Therapy"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Oxadiazoles"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pharmacology"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pneumonia"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pulmonary Medicine"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Respiratory Hypersensitivity"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Respiratory Insufficiency"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Respiratory System"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Toxicology"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Tuberculin Test"
    }
  ]
}